Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21. (Q55038614)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

1 reference

based on heuristic

inferred from title

Federico Pregheffi

8

object named as

Federico Garrido

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

author name string

Isabel Maleno

1

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

Carmen Maria Cabrera

2

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

Teresa Cabrera

3

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

Laura Paco

4

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

Miguel Angel López-Nevot

5

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

Antonia Collado

6

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

Antonio Ferrón

7

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

language of work or name

0 references

publication date

16 July 2004

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

56

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

4

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

244-253

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

The great escape: Is immune evasion required for tumor progression?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD8 T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MHC antigens and tumor escape from immune surveillance

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular basis for stool-based DNA tests for colorectal cancer: a primer for clinicians.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene expression in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low frequency of HLA haplotype loss associated with loss of heterozygocity in chromosome region 6p21 in clear renal cell carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Criteria to define HLA haplotype loss in human solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High frequency of altered HLA class I phenotypes in invasive breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MHC class I antigens, immune surveillance, and tumor immune escape.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphocyte-mediated immunosurveillance of epithelial cancers?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β2‐microglobulin inactivation in MSI‐positive tumors and LMP7/TAP2 downregulation in MSI‐negative tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor immunity at work in a melanoma patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of HLA expression during tumour development.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microsatellite analysis of microdissected tumor cells and 6p high density microsatellite analysis in head and neck squamous cell carcinomas with down-regulated human leukocyte antigen class I expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selection of metastatic tumour phenotypes by host immune systems

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High frequency of altered HLA class I phenotypes in laryngeal carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular strategies to define HLA haplotype loss in microdissected tumor cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15258706

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00251-004-0692-Z

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 June 2018

http://europepmc.org/abstract/MED/15258706

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55038614&oldid=2212635311"